Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis (Q35584564)

9 August 2017

0 references

Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis (English)

1 reference

9 August 2017

1 reference

1 reference

Shaheen E Lakhan

1

1 reference

PubMed ID

25800040

9 August 2017

Dominic N Velasco

series ordinal

2

1 reference

PubMed ID

25800040

9 August 2017

Deborah Tepper

series ordinal

3

1 reference

9 August 2017

20 March 2015

1 reference

9 August 2017

1 reference

9 August 2017

16

1 reference

9 August 2017

9

1 reference

9 August 2017

1773-1780

1 reference

Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

9 August 2017

1 reference

Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.

21 January 2018

1 reference

The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

21 January 2018

1 reference

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey.

21 January 2018

1 reference

Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

21 January 2018

1 reference

The burden of neuropathic pain: results from a cross-sectional survey.

21 January 2018

1 reference

The impact of neuropathic pain on health-related quality of life: review and implications

21 January 2018

1 reference

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

21 January 2018

1 reference

Clinical characteristics and economic costs of patients with painful neuropathic disorders

21 January 2018

1 reference

Diabetic neuropathy: clinical manifestations and current treatments

21 January 2018

1 reference

Diabetic neuropathy: mechanisms to management

21 January 2018

1 reference

Botulinum neurotoxin for pain management: insights from animal models

21 January 2018

1 reference

Do botulinum toxins have a role in the management of neuropathic pain?: a focused review

21 January 2018

1 reference

The role of botulinum toxin in management of pain: an evidence-based review

21 January 2018

1 reference

Evidence for the use of botulinum toxin in the chronic pain setting--a review of the literature

21 January 2018

1 reference

Future aspects of botulinum neurotoxins

21 January 2018

1 reference

Lost in a jungle of evidence: we need a compass

21 January 2018

1 reference

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

21 January 2018

1 reference

OnabotulinumtoxinA improves tactile and mechanical pain perception in painful diabetic polyneuropathy

21 January 2018

1 reference

Clinically significant changes in pain along the visual analog scale

21 January 2018

1 reference

Prospective validation of clinically important changes in pain severity measured on a visual analog scale

21 January 2018

1 reference

Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale

21 January 2018

1 reference

Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain

21 January 2018

1 reference

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/PME.12728

1 reference

9 August 2017

1 reference

PubMed ID

25800040